What is Liraglutide?
Liraglutide is a synthetic analog of human GLP-1 with a fatty-acid modification that prolongs circulation by promoting albumin binding. It was one of the first GLP-1 receptor agonists to gain broad use for type 2 diabetes and later became approved at a higher dose for chronic weight management.
How does Liraglutide work?
Liraglutide activates GLP-1 receptors in pancreatic, gastrointestinal, and central nervous system tissues. It increases glucose-dependent insulin secretion, suppresses inappropriate glucagon release, slows gastric emptying, and enhances satiety signals in appetite-regulating brain regions.
Primary Documented Uses
- Type 2 diabetes management (Victoza)
- Chronic weight management at obesity-dose formulation (Saxenda)
- Cardiovascular risk reduction in selected patients with type 2 diabetes
- Research comparator for newer incretin therapies
Research Summary
The SCALE clinical trial program demonstrated clinically meaningful weight loss in adults with obesity or overweight, while diabetes trials showed A1c reduction and cardiometabolic benefit. The LEADER cardiovascular outcomes trial found lower rates of major adverse cardiovascular events in high-risk patients with type 2 diabetes.
Legal and Regulatory Status
Liraglutide is FDA-approved as a prescription medication. It should be used only under medical supervision because of gastrointestinal side effects, gallbladder risks, and contraindications in certain endocrine tumor syndromes.
Frequently Asked Questions
What is Liraglutide?
Liraglutide is A daily GLP-1 receptor agonist approved for type 2 diabetes and chronic weight management, with a long record of clinical safety data.
How does Liraglutide work?
Liraglutide activates GLP-1 receptors in pancreatic, gastrointestinal, and central nervous system tissues. It increases glucose-dependent insulin secretion, suppresses inappropriate glucagon release, slows gastric emptying, and enhances satiety signals in appetite-regulating brain regions.
What does research say about Liraglutide?
The SCALE clinical trial program demonstrated clinically meaningful weight loss in adults with obesity or overweight, while diabetes trials showed A1c reduction and cardiometabolic benefit. The LEADER cardiovascular outcomes trial found lower rates of major adverse cardiovascular events in high-risk patients with type 2 diabetes.
Is Liraglutide FDA-approved or legally available?
Liraglutide is FDA-approved as a prescription medication. It should be used only under medical supervision because of gastrointestinal side effects, gallbladder risks, and contraindications in certain endocrine tumor syndromes.